Nuzenio

Fda Disputes Capricor

Fda Disputes Capricor news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 14 publisher sources 100/100 entity strength

Latest news

CAPR Stock Sinks After-Hours: Capricor Launches Legal Fight Over DMD Therapy Rollout Ahead Of FDA Review - StocktwitsStocktwits · Fri, 07 Aug 2026 21:24:04 GMT FDA Neurology Roundup: July 2026 - MedscapeMedscape · Wed, 05 Aug 2026 11:57:35 GMT FDA advisers reject evidence for Duchenne heart therapy - Muscular Dystrophy NewsMuscular Dystrophy News · Tue, 04 Aug 2026 17:04:06 GMT Capricor’s Duchenne AdCom Didn’t Fail on Science. It Failed on Statistics. - clinicaltrialvanguard.comclinicaltrialvanguard.com · Tue, 04 Aug 2026 07:38:27 GMT Capricor CEO won’t rule out legal action against FDA after negative adcomm - BioSpaceBioSpace · Fri, 31 Jul 2026 07:00:00 GMT FDA AdCom shuns Capricor’s DMD cell therapy amid data dispute - Pharmaceutical TechnologyPharmaceutical Technology · Thu, 30 Jul 2026 14:06:52 GMT Capricor plummets after FDA panel votes against Duchenne heart disease therapy - ReutersReuters · Thu, 30 Jul 2026 07:00:00 GMT FDA adcomm shoots down Capricor's Duchenne cell therapy after meeting marked by statistical dispute - Fierce BiotechFierce Biotech · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 21:24:04 GMTCAPR Stock Sinks After-Hours: Capricor Launches Legal Fight Over DMD Therapy Rollout Ahead Of FDA Review - Stocktwits

Wed, 05 Aug 2026 11:57:35 GMTFDA Neurology Roundup: July 2026 - Medscape

Tue, 04 Aug 2026 17:04:06 GMTFDA advisers reject evidence for Duchenne heart therapy - Muscular Dystrophy News

Tue, 04 Aug 2026 07:38:27 GMTCapricor’s Duchenne AdCom Didn’t Fail on Science. It Failed on Statistics. - clinicaltrialvanguard.com

Fri, 31 Jul 2026 07:00:00 GMTCapricor CEO won’t rule out legal action against FDA after negative adcomm - BioSpace

Thu, 30 Jul 2026 14:06:52 GMTFDA AdCom shuns Capricor’s DMD cell therapy amid data dispute - Pharmaceutical Technology

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

FDA9 live mentions Duchenne7 live mentions Capricor7 live mentions Deramiocel4 live mentions CAPR4 live mentions Muscular Dystrophy News3 live mentions Hours2 live mentions Capricor Launches Legal2 live mentions Fight Over DMD2 live mentions Therapy Rollout Ahead2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Fda Disputes Capricor.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.